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Summary 24 
Equine populations worldwide are at increasing risk of infection by viruses transmitted by biting 25 
arthropods including mosquitoes, biting midges (Culicoides), sandflies and ticks. These include the 26 
flaviviruses (Japanese encephalitis, West Nile and Murray Valley encephalitis), alphaviruses (eastern, 27 
western and Venezuelan encephalitis) and the orbiviruses (African horse sickness and equine 28 
encephalosis). This review provides an overview of the challenges faced in the surveillance, prevention 29 
and control of the major equine arboviruses, particularly in the context of these viruses emerging in 30 
new regions of the world.  31 
Introduction 32 
The rate of emergence of infectious diseases, in particular vector-borne viral diseases such as dengue, 33 
chikungunya, Zika, Rift Valley fever, West Nile, Schmallenberg and bluetongue, is increasing globally 34 
in human and animal species for a variety of reasons [1]. These include increased movement of 35 
animals and people worldwide, environmental and climate change, and human encroachment into 36 
natural habitats (taking domestic species with them). Equine arboviruses are no exception to this 37 
trend, and a number of authors have highlighted the potential for the introduction of various equine 38 
arboviruses to Europe [2-4]. 39 
Arboviruses are defined as viruses transmitted by biting arthropods, which include mosquitoes, biting 40 
midges (Culicoides), sandflies and ticks. Arboviruses replicate in the body of the insect and are, 41 
therefore, distinct from viruses with a mechanical mode of transmission (e.g. equine infectious 42 
anaemia virus is transmitted on or in the mouthparts of insects without replication). The equine 43 
arboviruses discussed in this review are listed, with their abbreviations, in Table 1. Although there are 44 
similarities in the transmission cycles of some of these viruses, the details are virus-specific and some 45 
are particularly complex. Similarities in clinical presentation and cross-reactivity of antibodies 46 
between related viruses can lead to initial misdiagnosis and delayed identification of an emerging 47 
arbovirus. For example, the first human cases of WNV infection in the USA were initially thought to be 48 
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caused by SLEV infection [5]. In this review, the major challenges presented by equine arboviruses in 49 
relation to vector roles, surveillance, control and risk management are summarised. 50 
Equine Arboviruses 51 
Alphavirus and Flavivirus Disease 52 
The main flavi- and alpha-viruses that affect horses share some similarities: they are transmitted by 53 
mosquitoes, and viruses of both genera cause encephalitic disease in both horses and humans. Major 54 
flaviviruses known to affect equids include Japanese encephalitis virus (JEV), WNV and Murray Valley 55 
encephalitis virus (MVEV) (Table 1). Major alphaviruses of horses include eastern, western and 56 
Venezuelan equine encephalitis viruses (EEEV, WEEV and VEEV, respectively), Ross River virus (RRV) 57 
and Getah virus (GETV).  58 
Equine morbidity and mortality information for mosquito-borne viruses affecting horses is presented 59 
in Chapman et al. [6]. Inapparent infections with limited clinical signs (e.g. transient pyrexia) are 60 
common with the encephalitogenic viruses, as a result of which, the proportion of deaths per 61 
diagnosed cases (case-fatality rate) can be very high. For example, the average fatality rate reported 62 
for cases of West Nile encephalitis in the United States between 1999 and 2006 was 30–40% [7]. 63 
However, retrospective estimates suggest that less than 10% of infected horses develop encephalitis. 64 
This figure was confirmed in a prospective study involving 37 unvaccinated horses in which only 2 of 65 
25 animals (8%) that seroconverted developed encephalopathy, which was fatal in one case [8]. 66 
Although around 80% of surviving horses recover in 3–4 weeks, a small proportion have residual 67 
neurological deficits [9]. In addition to inapparent infections, strain-dependent differences in virulence 68 
can lead to wide variation in morbidity and mortality or case fatality estimates. However, in contrast 69 
to WNV, JEV, EEEV and VEEV, morbidity rates of MVEV and RRV are low and they rarely cause fatal 70 
disease, and GETV is often subclinical with affected horses usually recovering completely [10].  71 
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Clinical signs in horses that are infected with the encephalitogenic viruses (WNV, JEV, MVEV, EEEV, 72 
WEEV, and VEEV) include a variety of neurological abnormalities. However, there is a significant 73 
degree of overlap between clinical presentation of these diseases (clinical signs of ataxia and paresis 74 
are common to all; Table 2), and it is this that can present a challenge in terms of clinical diagnosis, 75 
particularly where there is overlapping distribution.  76 
Flavivirus epidemiology and ecology 77 
The flaviviruses that affect horses share characteristics in their transmission cycles. In general, these 78 
viruses are maintained in an enzootic cycle (i.e. they are transmitted between wild animals, usually 79 
birds) and horses (and humans) are infected as “incidental” or “dead-end” hosts (Figure 1).  Dead-end 80 
hosts usually do not produce sufficiently high viraemia to infect mosquitoes, and therefore are not 81 
involved in ongoing transmission. Although the reservoir hosts are avian, large outbreaks of JEV may 82 
be associated with efficient amplification of virus in pigs, which also produce high levels of viraemia 83 
[11].  84 
West Nile virus has the most widespread geographical distribution (Figure 2a) and the largest known 85 
vector and host range of all mosquito-borne flaviviruses [12]. Its ability to occupy a wide geographical 86 
area is due to its broad host and vector range. In contrast, JEV and MVEV have more restricted ranges 87 
(Figure 2b, 2c). However, it is not clear whether host or vector range may be more important in 88 
restricting their distribution. 89 
Alphavirus epidemiology and ecology 90 
Although like the flaviviruses, alphaviruses are transmitted by mosquitoes, their life cycles tend to be 91 
more complex. The eastern, western and Venezuelan equine encephalitic viruses (EEVs) are all 92 
restricted to the Americas.  Eastern EEV affects horses, swine and humans as dead-end hosts [13]. It 93 
was traditionally thought to be maintained in an enzootic cycle between passerine birds and 94 
mosquitoes. However rodents are now thought to be epidemiologically significant hosts in South 95 
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America, and possibly in Florida [14; 15]. The ecology of South American EEEV is poorly understood 96 
[16].  Western EEV is maintained in an enzootic cycle between mosquitoes and birds, from Canada to 97 
Argentina [3], with horses and humans affected as dead-end hosts [17; 18]. Venezuelan EEV circulates 98 
in enzootic cycles between rodent hosts and mosquito vectors in Mexico, Central and South America 99 
[19]. The virus is antigenically complex with six antigenic subtypes within which there are antigenic 100 
variants. The E2 envelope glycoprotein determines equine viraemia and virulence, and mutations in 101 
the E2 gene can cause avirulent strains to be more efficiently amplified in horses. This results in an 102 
epizootic cycle during which virus amplification in the horse is sufficient to result in mosquito infection 103 
(i.e. the horse is no longer a dead-end host) and this is thought to significantly increase the risk of 104 
human infection [20]. Epizootics of VEEV have generally occurred in South America, although an 105 
epizootic occurred in Texas in 1971, affecting an estimated 10% of the equine population in the region 106 
and 1,500 equids died [21; 22]. Humans are typically considered dead-end hosts, but there is some 107 
recent evidence to suggest that humans may develop high enough virus titre to continue epidemic 108 
transmission in urban environments [23]. 109 
Ross River virus is active each year in most regions of Australia and has also caused epidemics in Papua 110 
New Guinea, the Solomon Islands, Fiji, New Caledonia and the Cook Islands. Epidemic polyarthritis due 111 
to RRV infection is the most common arboviral disease in humans in Australia [24]. The major enzootic 112 
cycle of RRV involves members of the macropod (i.e. kangaroo) family as the vertebrate host, although 113 
other mammals have been suggested as reservoir hosts [25]. There is evidence that both horses and 114 
humans are able to infect vectors and at least one outbreak thought to be due to human air travel has 115 
occurred [26-29]. 116 
Getah virus is found from Eurasia to Australasia (Figure 3e). The natural transmission cycle is not well 117 
described or studied, although swine are thought to play an important role in amplification [30]. Getah 118 
virus appears to have a wide host range, although the main enzootic cycle is thought to be between 119 
mammals (particularly rodents) and mosquitoes, as birds show lower seroprevalence rates [10; 30]. 120 
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Horses produce a high enough viraemic titre during an epidemic to infect mosquitoes and direct horse-121 
to-horse transmission has been demonstrated experimentally, although it is unlikely to be a common 122 
mechanism for natural infection [31].  123 
Orbiviruses 124 
African horse sickness virus 125 
African horse sickness (AHS) is a disease almost exclusively of equids. It is endemic in sub-Saharan 126 
Africa, but outbreaks have occurred elsewhere including the Middle East and India, and the western 127 
Mediterranean (reviewed in [32]).  128 
The virus infects capillary endothelial cells in the myocardium, lung, spleen and liver. A mild form 129 
(horse sickness fever) involves oedema of the supraorbital fossae and fever, and occurs in donkeys 130 
and zebra and horses that have some immunity or are infected with a less virulent strain [33]. The 131 
pulmonary form causes rapid respiratory failure and is associated with case fatality rates that can 132 
exceed 95% [34]. The cardiac form causes oedema of the head and neck, progressing to dyspnoea, 133 
cyanosis, abdominal pain and heart failure and case fatality rates are around 50%. A mixed form of 134 
AHS is common with a mortality rate of around 70% [33].  135 
Transmission occurs via the bite of infected midges of the genus Culicoides. All recorded outbreaks of 136 
AHS have occurred within the geographic range of the primary vector, Culicoides imicola, although in 137 
recent years a second vector, C. bolitinos, has been identified in South Africa [35]. The transmission 138 
cycle of AHSV involves only equids as hosts; other infected mammals (dogs) appear to be dead-end 139 
hosts [36; 37]. Species that produce a prolonged viraemia and have low disease mortality, such as 140 
zebra and donkeys, act as reservoir hosts [38]. As there is no carrier state, persistence of AHSV is 141 
believed to rely on sufficient density and renewal of susceptible reservoir hosts [32; 39].  142 
Equine encephalosis virus 143 
Equine encephalosis virus (EEV) usually causes subclinical or mild disease in horses. Clinical signs 144 
include oedema of the back legs, eyelids and lips. As for AHSV, transmission is via C. imicola and the 145 
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disease is endemic in temperate regions of Africa [40; 41], although there has been a recent outbreak 146 
in Israel [42]. Veterinarians and horse owners in at-risk regions should be aware that mild clinical signs 147 
including oedema of the eyelids and lips may be due to EEV rather than AHSV.  148 
Others 149 
Several other viruses belonging to the families described here and some belonging to other families 150 
may infect horses but their impact is more limited due to the sporadic nature of infection or 151 
geographic restriction (Table 1) [43-45]. Others are only just being recognised as potential causes of 152 
disease in horses. Since 2013, Bunyamwera virus, an Orthobunyavirus, has emerged as a cause of 153 
neurological disease and possibly abortion in horses in Argentina [46; 47]. Clinical signs include 154 
apparent disorientation, weakness, visual deficits, tongue protrusion, recumbency and death. 155 
Transmission cycles are poorly characterised, although mammals are considered to be amplifying 156 
hosts and most isolates have been recovered from mosquitoes. Seroprevalence among birds in 157 
Argentina indicate that they could be in involved as endemic hosts [48].  158 
Meeting the challenges of diagnosis and control of equine 159 
arboviruses 160 
Diagnosis and surveillance 161 
The overlapping geographical ranges of the flavi- and alphaviruses and the overlap in clinical signs 162 
between these and other viruses can make clinical diagnosis challenging, particularly in some regions 163 
of the world. For example, differential diagnosis for infections causing non-suppurative encephalitis 164 
in horses in Australia include MVEV, RRV, WNV (Kunjin), a strain of WNV, and Hendra virus [49]. 165 
Similarly, various combinations of WNV, EEEV, WEEV and VEEV overlap in some regions of the 166 
Americas, particularly in Mexico and Central America. A recent serosurvey of 246 horses in Costa Rica 167 
revealed prevalence of 57% for WNV, 62% for EEEV, 43% for VEEV, and 17% for WEEV [50]. In many 168 
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regions of the world, only outbreaks of WNV have been reported in horses, but an early and accurate 169 
diagnosis is important to rule out emergence of other flavi- or alpha-viruses.  170 
Although challenging, clinical diagnosis remains the cheapest approach to surveillance for equine 171 
arbovirus outbreaks and can be enhanced by adopting a ‘multivariate syndromic surveillance’ system 172 
in which data are compiled from various sources. For example, taking weekly time series data on 173 
occurrence of nervous signs consistent with encephalitic disease in horses and mortality in both horses 174 
and wild birds has been used to identify outbreaks of WNV in France [51]. Laboratory confirmation is 175 
still required, and to be effective, this approach requires communication of data between various 176 
agencies including veterinary bodies and equine industry stakeholders.  177 
Diagnostic tests for equine arboviruses have a number of disease-specific limitations. For many 178 
diseases, detection of virus nucleic acid is now favoured over traditional virus isolation. Some 179 
arboviruses are readily detected in blood using polymerase chain reaction (PCR)-based techniques, for 180 
example, for VEEV, viraemia occurs with the onset of pyrexia and lasts for 5–6 days. For AHSV, the 181 
World Organization for Animal Health (OIE) recommends that virus is isolated for serotyping so that a 182 
vaccine containing the relevant serotype can be implemented, although this could be achieved by 183 
direct sequencing [52]. However, as already described, the horse is a ‘dead-end’ host for some equine 184 
arboviruses such as the flaviviruses WNV and JEV. As a result of the limited and transient viraemia, 185 
even sensitive PCR-based diagnostic tests may yield false-negative results for these viruses. Therefore, 186 
although virus can be detected in post mortem tissues, particularly the brain and spinal cord [52], 187 
diagnosis frequently relies on serological tests. 188 
Although diagnosis of equine and human flavivirus infections relies heavily on antibody detection, this 189 
is complicated by high levels of serological cross-reactivity among flaviviruses, particularly in rapid 190 
assays such as enzyme-linked immunosorbent assay (ELISA). Testing for IgM antibodies, which indicate 191 
the most recent infection, is preferable as IgG antibodies can remain in circulation long after the acute 192 
phase of infection. A positive diagnosis by ELISA usually requires confirmation by the more specific 193 
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virus neutralisation test; this is time-consuming and costly due to the requirement for BSL-3 194 
containment to handle infectious virus. To address these issues, new approaches are being developed, 195 
including rapid neutralisation tests based on pseudotyped viruses that do not require high levels of 196 
biosafety containment (reviewed in [53]). Multiplex serological assays (e.g. using micro-bead 197 
technology [54]) are desirable to speed up identification of pathogens and enable a syndromic 198 
approach to diagnosis to be undertaken (e.g. for neurological disease).  199 
Vaccine challenges 200 
Equine vaccines are available for most of the mosquito-borne equine arboviruses described in regions 201 
where they are endemic, with the notable exceptions of RRV and MVEV. In the USA, multivalent 202 
vaccines are available that include WNV, EEEV, WEEV and VEEV. Although effective vaccines against 203 
WNV are available, there may be a desire to prohibit vaccination of horses in some countries so that 204 
they can fulfil the role of a sentinel species [55; 56]. As vaccines become available, tests with 205 
differentiation of infected from vaccinated animals (DIVA) potential are desirable in order to 206 
determine whether an animal has seroconverted in response to natural infection or vaccination. This 207 
is particularly the case when attempting to control an outbreak of an emerging virus to prevent it from 208 
becoming established. For example, using a DIVA approach enables ring vaccination to be performed 209 
whilst still allowing any spread of the virus to be monitored. Three different vaccines for WNV are 210 
commercially available including the multivalent inactivated (killed virus) vaccine, a live canarypox 211 
virus vectored vaccine and a DNA vaccine. The latter two vaccines only contain a portion of the viral 212 
genome (expressing the prM/E proteins) and therefore have the potential to be used in a DIVA 213 
approach in combination with an assay that detects antibodies to other viral proteins (e.g. the NS1 214 
non-structural protein [57]).  215 
The existence of nine serotypes of AHSV presents a particular challenge for vaccination. The control 216 
of AHSV in South Africa depends on a live-attenuated AHSV vaccine produced by Onderstepoort 217 
Biological Products. This vaccine contains seven of the serotypes delivered as two separate injections, 218 
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and it requires two or three doses to generate an adequate immune response to all of the serotypes 219 
in the vaccine. Reassortment (i.e. exchange of gene segments between vaccine and field strains) and 220 
reversion to virulence have been demonstrated [58]. Consequently, the live-attenuated vaccine is not 221 
licensed for use in countries where the virus is not endemic and alternative recombinant vaccines are 222 
being actively developed.  223 
Arbovirus emergence: challenges in risk prediction 224 
In order to understand the potential impacts of globalization and climate change on the global disease 225 
patterns of equine arboviral disease, knowledge of the complexities of transmission cycles, vector life 226 
cycle and the effects of climate change on the vector and vector infection dynamics are vital. In 227 
general, it is difficult to predict whether (or when) vector-borne diseases could become established in 228 
new areas. Due to the involvement of multiple different host types and vectors for some of the equine 229 
arboviruses, risk prediction for epidemic transmission and for virus establishment and endemicity is 230 
challenging.  There is often a lack of information on the presence of vectors, their vectorial capacity, 231 
and the competence of potential reservoir hosts, which may not be present (and therefore studied) 232 
in endemic areas.  233 
 234 
Virus introduction  235 
Equine arboviruses cannot be controlled solely by animal trade policies as some can be introduced 236 
into new regions by movement of viraemic people, migratory birds, or incidental transport of infected 237 
vectors as well as by animal movements. It is important to remember that movement of infected 238 
individuals does not pose the same risk if they are a ‘dead-end’ host, as is the case for WNV. Therefore, 239 
disease introduction may occur without risk of onward transmission due to the absence or low titre 240 
of virus in the blood at the time of importation. For example, a horse imported into the UK from 241 
Europe had neurological signs and antibodies against WNV but no detectable viraemia at the time of 242 
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testing [59]. If local vectors are infected, then clinical cases in horses or humans may occur. Occurrence 243 
of a small number of autochthonous (locally-acquired) infections could occur without local reservoir 244 
host involvement, where all vectors are infected from imported hosts. This type of locally-acquired 245 
infection may occur without being detected as many infections with equine arboviruses are 246 
subclinical. In certain cases, a small number of onward transmission events could occur without a 247 
vector contacting the importation host, for example by blood transfusion, as has been recorded in 248 
humans [60]. It has also been suggested that bird-to-bird transmission of WNV may occur in some 249 
species and contribute to overwintering of the virus [61]. A competent vector, however, is required 250 
for epizootic spread.  251 
Ongoing transmission in the case of a VEEV epizootic strain or RRV would require only susceptible 252 
equids or humans and competent vectors, and in this case equids could represent a public health risk. 253 
In the case of other equine mosquito-borne pathogens, competent local reservoir hosts are required 254 
for ongoing transmission, as with the introduction of WNV into the USA. 255 
Mathematical and epidemiological modelling can help to identify subpopulations, regions and periods 256 
when there is a higher risk of entry and spread of specific diseases, enabling the occurrence of 257 
outbreaks to be anticipated through targeted surveillance. For example, a study to identify hotspots 258 
for potential introduction of EEEV, WEEV, VEEV and JEV to Europe through live animal trade 259 
demonstrated that the risk was higher for EEEV than the other three viruses, which was mainly 260 
associated with trade in exotic pet species such as rodents, reptiles or caged birds [2]. The risk was 261 
greatest in Belgium, the Netherlands and northern Italy, highlighting that managing the risk of 262 
introduction of exotic arboviruses to Europe as a result of animal trade requires a transboundary 263 
approach.  264 
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 265 
Vector presence  266 
The distribution of equine arboviruses is dependent on the presence of the relevant insect vector 267 
(Table 1). Many mosquito species act as vectors of WNV, hence the global distribution of this disease. 268 
For a number of the arboviruses, the distribution of outbreaks does not extend to all regions of vector 269 
occurrence. Therefore, these areas may be considered at risk of emergence. 270 
The distribution of the main vector of AHSV (Culicoides imicola) extends from South Africa to Southern 271 
Europe and across the Middle East to South East Asia and Southern China [62]. African horse sickness 272 
virus was introduced into Spain in 1987 when a group of zebra were brought by ship from Namibia 273 
and were quarantined outdoors near Madrid. At the time, it was not known that C. imicola, was 274 
present across the southern half of Spain. The ensuing epizootic resulted in the death of at least 1000 275 
equids over a 4-year period, and affected three countries (Spain, Portugal and Morocco) [63]. This 276 
emphasises the need for vector surveillance in order to accurately predict the risk of introduction of 277 
equine arboviruses into different regions. Some countries, such as Italy, also have AHSV vector 278 
populations but have not recorded outbreaks of disease. As C. imicola is also the main vector of EEV 279 
and the transmission cycle is similar, the same regions that are at risk of AHSV emergence may also 280 
be considered at risk of EEV emergence.  281 
The presence of an alternative species to the main known vector species can have a profound impact 282 
on the epidemiology of incursion, but this is difficult to predict. For example, the main insect vector 283 
of JEV in Asia is Culex tritaeniorhynchus, which can be infected when there are very low levels of 284 
viraemia in the host. However, when there was an incursion of JEV in northern Australia, the main 285 
vector was Culex annulirostris [64; 65], which is thought to require higher titres to become infected. 286 
It is not clear whether JEV failed to become endemic in northern Australia for this reason or due to 287 
the presence of other flaviviruses conferring cross-protection to hosts, or because Cx. annulirostris 288 
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preferentially feeds on marsupials and not wading birds or pigs, the reservoir and amplifying hosts, 289 
respectively, of JEV [66]. 290 
For some other viruses, such as EEEV, it is not clear whether virus introduction into new regions (e.g. 291 
Europe) would find adequate populations of competent vectors for ongoing transmission. Of the 292 
major vectors of EEEV in the Americas, only Cs. morsitans is present in Europe [67]. There are many 293 
other species of mosquito implicated as possible vectors of EEEV. However, without further 294 
information such as vector competence and ecological information on vector populations and host–295 
vector interaction, it is not possible to accurately predict whether mosquito populations present in 296 
Europe would be capable of facilitating epidemic or endemic transmission. Similarly, the major vector 297 
of WEEV (Cx. tarsalis) and the major vectors of enzootic VEEV belonging to the genus Cx. melanoconion 298 
are only found in the Americas [19; 68; 69]. For the epidemic form of VEEV, many other mosquito 299 
species in the genera Psorophora, Aedes (Ochlerotatus) and Culex act as vectors [3], and species of 300 
these genera are found worldwide.  301 
The major vector of MVEV (Cx. annulirostris) is confined to Oceania [68; 70] (not including New 302 
Zealand), and the distribution of outbreaks reflects this. RRV is active each year in most regions of 303 
Australia. Important vectors include Aedes camptorhyncus, Ochlerotatus vigilax and Cx. annulirostris 304 
[24]. The distributions of Cx. annulirostris and Oc. vigilax extend to South East Asia; for Oc. vigilax, this 305 
includes Japan and Taiwan [68].  306 
For BUNV and GETV, transmission is not well studied, but Culex spp. are implicated in GETV 307 
transmission and the virus has been isolated from Aedes spp. in Siberia [71]. 308 
Vector introduction 309 
The risk of arbovirus vector introduction is important in both endemic and non-endemic regions. 310 
Invasive vectors, i.e. introduced species that have increased in number and regional range [72], 311 
include vectors of equine arboviruses such as Aedes albopictus, Culex pipiens, Culex quinquefasciatus 312 
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and Culicoides imicola [72; 73]. The introduction of an invasive vector with high vector competence 313 
could have significant ecological impact, even in endemic areas of virus transmission, and in disease-314 
free regions increase the risks posed by virus introduction. Surveillance for invasive mosquito species 315 
is therefore carried out by governmental organisations, for example by Public Health England in the 316 
UK.  317 
Introduction may occur through human activity such as the movement of people, livestock or goods. 318 
The used tyre trade has been implicated in long distance sea transport of mosquito eggs of Aedes 319 
mosquitoes [74] and desiccation-resistant eggs are associated with increased probability of species 320 
introduction [72]. Mathematical modelling applied to assess the risk of WNV-infected mosquitoes 321 
being introduced to the UK from America led to the conclusion that each summer there is a high risk 322 
of at least one WNV-infected mosquito arriving at Heathrow airport, which has a moderate density of 323 
susceptible vector and bird species that could allow local dissemination of the virus [75]. The airport 324 
is also in a region with a high density of horses [76].  325 
Some barriers to expansion of vector range by natural dispersal include non-vegetated corridors, 326 
mountain ranges and large bodies of water [77]. However, Culicoides, being extremely small and light, 327 
can be transported long distances by the wind, and it is thought that plumes of wind prevailing from 328 
continental Europe were responsible for the introduction of both Schmallenberg and bluetongue 329 
viruses into the UK [78]. Interestingly, an outbreak of African horse sickness in 1966 occurred just 330 
across the Strait of Gibraltar, which separates southern Spain from North Africa [79].  331 
Vector–host interaction 332 
The details of vector–host interaction are complex and vary depending on the ecosystem. For some 333 
of the equine arboviral diseases, such as GETV, Bunyamwera and to an extent EEEV in South America, 334 
they have not been well studied. This lack of knowledge creates major challenges in predicting 335 
potential outcomes of an arboviral disease outbreak in a non-endemic region. 336 
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Apart from AHSV and epidemic VEEV, in which the amplification host is the equid, multiple hosts are 337 
necessary for completion of the transmission cycle of the arboviral diseases described in this review. 338 
Therefore, vectors must necessarily feed from more than one host species in order to infect 339 
susceptible hosts. Many of the equine encephalitis viruses have avian reservoir hosts. Vectors that 340 
blood-feed from both birds and mammals are therefore required for equine infection to occur. Vectors 341 
that bite multiple host types are commonly referred to as ‘bridge vectors’. Some of these bridge 342 
vectors are indiscriminate feeders whereas others mainly feed on avian species, and occasionally feed 343 
on large mammals. This can therefore lead to infection in these species, for example in the case of 344 
Culex pipiens and WNV [80] or Culiseta melanura and EEEV [81], both of which cause infections in 345 
horses and humans. 346 
 347 
Vector life cycle and climate dependence 348 
In order to appreciate how climate change might alter the ability of equine arboviruses to become 349 
established in temperate regions, it is necessary to consider how it may affect vectorial capacity, which 350 
is a measure of the efficiency of vector-borne disease transmission by a vector population.  351 
Vectorial capacity is usually expressed as the number of infective bites received daily by a single host. 352 
It is comprised of the average daily vector biting rate (the daily probability of a vector feeding on a 353 
susceptible host), vector competence (the proportion of vectors capable of being infected; this may 354 
be determined genetically), the extrinsic incubation period, and vector lifespan [82; 83], all of which 355 
depend on temperature to a greater or less extent. 356 
Adult female mosquitoes and Culicoides feed on blood to enable egg production. They become 357 
infected when they feed on a viraemic host and, following virus replication in the vector and spread 358 
to the salivary glands, transmit the virus when they subsequently feed on a susceptible host. 359 
Therefore, the vector biting rate depends on the time between laying egg batches (the gonotrophic 360 
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cycle length). As the ambient temperature increases, the gonotrophic cycle decreases, leading to more 361 
frequent feeding, and creating more opportunities for onward transmission of virus. 362 
The extrinsic incubation period (EIP) is defined as the time between a vector obtaining an infective 363 
blood meal and being able to infect a susceptible host [84]. The EIP for arboviruses has been shown 364 
to be temperature dependent; EIP shortens with increasing environmental temperature up to a 365 
maximum transmission efficiency, though some studies detect a subsequent decrease as the 366 
temperature rises further [85; 86]. There may also be strain differences in the relationship between 367 
temperature and EIP. For example, WNV is thought to have expanded rapidly across the US because 368 
of genome changes in the strain that became established resulting in a shorter EIP in Culex mosquitoes 369 
than the strain that was originally introduced [87; 88]. This advantage is also greater with increased 370 
temperatures [89]. 371 
Increases in temperature generally accelerate mosquito development [90], thereby reducing 372 
longevity. The impact of raising temperature is greater on some species than others, but the reduction 373 
in longevity will act to reduce vectorial capacity [91]. 374 
The vector biting rate also depends on the density of vectors in relation to the density of the host. 375 
Increases in vector populations may result from other consequences of climate change, for example 376 
decreased rainfall has been associated with a higher incidence of WNV infection in horses [92].  377 
Overwintering  378 
A characteristic of equine arboviruses in temperate regions is that transmission tends to stop, or at 379 
least not be observed, during the cold season when the vectors are not active, but they then reappear 380 
the following year. Potential mechanisms by which an arbovirus is able to ‘overwinter’ are virus–vector 381 
specific and are unknown or poorly understood in many cases. In mosquitoes, transovarial (vertical) 382 
transmission has been proposed as an over-wintering mechanism for several viruses, for example RRV 383 
[93]. Alternatively, some mosquito species hibernate as adults and may harbour virus over winter; for 384 
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example, WNV has been demonstrated in overwintering adult Culex pipiens [94; 95]. In contrast, EEEV 385 
has not been found in hibernating mosquitoes in endemic areas [96]. Culicoides species do not 386 
hibernate, but overwinter in the larval stage. However, vectors of AHSV may be active in some 387 
temperate regions throughout the year and therefore low level virus transmission is proposed as a 388 
potential overwintering mechanism [97]. Laboratory studies suggest that at 10°C, low levels of AHSV 389 
may persist in Culicoides, and these vectors can develop transmissible infections when the 390 
temperature rises to 25°C [98]. The zebra also represents an overwintering opportunity for AHSV, as 391 
virus has been isolated from zebra up to 7 weeks post infection [38; 99]. Other vertebrate hosts that 392 
maintain a prolonged viraemia, such as bats and reptiles, have been suggested as potential 393 
overwintering hosts for JEV [100; 101], WNV [102], WEEV [103; 104] and EEEV [105]. Whilst it is 394 
apparent that many arboviruses overwinter in temperate regions, uncertainty about the underlying 395 
mechanisms presents a challenge when trying to determine whether a virus with expanding range will 396 
become endemic in a new region. For example, detection of persistent viral RNA in a vector or host 397 
species does not necessarily imply that there is sufficient infectious virus to subsequently re-establish 398 
an active transmission cycle. 399 
Conclusion 400 
Equine populations worldwide are at increasing risk of arboviral disease. Better understanding of 401 
factors that alter the likelihood of emergence and transmission of these viruses are important for 402 
accurate surveillance and control, enabling timely evidence-based information about disease risk and 403 
control to be conveyed to appropriate veterinary and equine industry stakeholders. In addition, it is 404 
important that equine veterinary surgeons are aware of the clinical signs of arboviral diseases and that 405 
different equine arboviral diseases may present with similar clinical signs. There is also the potential 406 
for emergence of new arboviruses in the future. Further advances in the development of diagnostic 407 
tests for rapid and accurate confirmation of disease and development of effective vaccines against 408 
some equine arboviruses are also required. 409 
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Table 1. The main equine arboviruses 775 
Family / genus Virus Abbr. Major vectors Zoonotic Major hosts involved in 
transmission 
Toga~/Alpha~ Eastern equine encephalitis  EEEV Culiseta melanura, Aedes 
taeniorhynchus [113] 
Y Passerine birds, rodents 
 Getah  GETV Aedes vexans niponii, Culex 
spp. [10; 24;114] 
N Swine 
 Ross River  RRV Aedes camptorhyncus, Culex 
annulirostris [24] 
Y Marsupials 
 Western equine encephalitis  WEE
V 
Culex tarsalis, Culiseta 
melanura [113] 
Y Passerine birds 
 Venezuelan equine 
encephalitis  
VEEV Enzootic form, Culex 
melanoconion spp. 
Epizootic form – wide vector 
range including Psorophora 
and Ochlerotatus spp.  [3] 
Y Rodents 
 Highlands J HJV Culiseta melanura [115] Y Passerine birds 
 Sindbis SINV Culex spp. Culiseta spp. [116] Y Birds 
Flavi~/ Flavi~ Japanese encephalitis JEV Culex tritaeniorhynchus, 
vishnu complex spp., gelidus 
[117; 118] 
Y Waterbirds, swine 
 Murray Valley encephalitis MVEV Cx. annulirostris [70] Y Waterbirds 
 West Nile virus WNV Many Culex spp. some of the 
most important include  Culex 
pipiens, tarsalis, modestus, 
quinquefasciatus [95; 119; 120]  
N Birds (rodents & reptiles) 
 Usutu USUV Culex pipiens [121] (Y) Birds 
 Powassan POW
V 
 (Y) Small mammals 
 Louping ill LIV  Ixodes ricinus [122] (Y) Sheep, red grouse 
Reo~/Orbi~ African horse sickness AHSV Culicoides imicola, bolitinos 
[123] 
N Equids 
 Equine encephalosis EEV Culicoides imicola [41] N Equids 
34 
      
      
Bunya~/Orthobuny
a~ 
Bunyamwera virus BUNV   Small mammals 
 Shuni SHUV Culicoides, Culex theilieri? 
[124] 
(Y) ? 
 Main Drain MDV Culicoides variipennis, other 
culicoides spp.? [125; 126]  
(Y) Small mammals 
 Snowshoe hare SSHV Aedes spp., Culiseta spp. [127; 
128] 
Y Small mammals 
 776 
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Table 2. Common and important clinical signs of mosquito-borne arboviral diseases in horses 777 
Clinical sign 
Virus 
WNV1 JEV2 MVEV3 EEV4 WEEV4 VEEV5 RRV6 Getah7 
Pyrexia         
Gait abnormalities / ataxia         
Paresis         
Paralysis         
Hyperexcitability         
Impaired vision / blindness         
Seizures         
Dromomania / circling         
Muscle fasciculations         
Inability to swallow         
Head pressing         
Colic-like signs         
Stiffness         
Oedema         
Lymphadenopathy         
Flaccid lips / tongue protrusion         
Urticaria / skin eruptions         
Hypersensitivity         
Cataplexy / narcolepsy         
Cranial nerve deficits         
Neck rigidity         
Radial paralysis         
36 
      
Profuse sweating         
Teeth grinding         
Low head carriage         
Drooping ears         
Swollen eyelids         
1Reference [129]; 2References [129-132]; 3Reference [49]; 4Reference [17]; 5References [17; 133; 134]; 778 
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Figure legends 784 
Figure 1. Example transmission cycles of equine arboviruses: (a) Murray Valley encephalitis virus, 785 
which has a simple transmission cycle in which the horse is a ‘dead-end’ host similar to other 786 
arboviruses such as West Nile virus; (b) Venezuelan encephalitis virus, which has enzootic and 787 
epizootic cycles; and (c) African horse sickness virus.  788 
Figure 2. Global distribution, by country, of equine flaviviruses: (a) West Nile virus [95; 106-109]; (b) 789 
Japanese encephalitis virus [110; 111]; (c) Murray Valley encephalitis virus [112]. 790 
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